PMID: 42195228

5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management.

Roidos Christos, Sountoulides Petros, Papathanasiou Konstantinos, Symeonidis Asterios, Mykoniatis Ioannis

Medicina (Kaunas, Lithuania) · 2026

Vol. 62, Issue 5

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansMaleProstatic Hyperplasia5-alpha Reductase InhibitorsFinasterideDrug Therapy, CombinationDutasterideAdrenergic alpha-Antagonists

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.